Flywheel, a leading data management platform for biomedical research and collaboration, is creating a federated data network aimed at improving artificial intelligence (AI) for breast imaging.

November 28, 2022 — Flywheel, a leading data management platform for biomedical research and collaboration, is creating a federated data network aimed at improving artificial intelligence (AI) for breast imaging. Funded in part by the National Institutes of Health (NIH), the federated network will support breast imaging AI research and collaboration on a scale not previously possible.

Two Flywheel technologies underpin the project. Flywheel Discovery, a cohort discovery tool, will connect with the imaging archives, mammography information systems, and EHRs of participating healthcare providers to identify relevant breast imaging data and curate it to common standards. Summaries of the datasets will then be published on Flywheel Exchange, a next-generation platform for research data sharing, where they can be browsed by researchers and licensed for secure use.

More diverse data is sorely needed by AI developers. Currently, data from health systems in just a few states makes up the majority of training data for deep learning algorithms, while broad swaths of the country are “data deserts” with little to no representation. This can contribute to bias in AI and further compound the disparate outcomes between populations of breast cancer patients. Given the shortage of breast imagers in many communities, providers need the most accurate AI tools possible to assist radiologists in increasing efficiency and quality of care.

Flywheel Exchange keeps patient data in place, simplifying compliance with HIPAA and IRB requirements for researchers. Testing and improving AI through federated analysis and federated learning is accomplished through moving the algorithm(s), rather than the data, across institutional lines. Healthcare providers retain full possession of patient data, while the algorithm being trained “visits” the data where it resides and carries weighted scores back to researchers. As healthcare providers embrace this approach, federated learning has the potential to dramatically improve the amount and diversity of data available to the research community.

“We are creating the complete data science stack to address the all-too-common challenges of healthcare researchers and AI developers,” said Jim Olson, CEO of Flywheel. “This solution combines both federation capabilities and the data science infrastructure to capture data and ensure consistent curation. Without that, researchers spend 80% of their time on menial datawrangling tasks. We’re creating the tools for data owners and data consumers to find each other and collaborate with unprecedented efficiency so they can make breakthroughs in care.”

Flywheel plans to unite academic medical centers, community health systems, and essential hospitals on its network, further building the catalog of data that AI developers, life sciences companies, and other researchers can license to power their research.

For more information: www.flywheel.io

Find more RSNA22 coverage here


Related Content

Feature | Cardiac Imaging | Kyle Hardner

Advances in coronary CT angiography (CCTA) have reached the point where image quality and AI capabilities are creating ...

Time February 06, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Lung Imaging

Feb. 3, 2026 — RevealDx, a leader in the characterization of lung nodules, recently announced FDA clearance of RevealAI ...

Time February 04, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...

Time February 03, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
Subscribe Now